Lataa...
The potential role of TNFα in 2019 novel coronavirus pneumonia
The outbreak of 2019 novel coronavirus has spread rapidly in multiple countries. We report the first case of 2019-nCoV infection in a patient with Ankylosing Spondylitis (AS), who was a biological agent (anti-TNFα) user in Wenzhou, China, and describe the clinical course and management of the case.
Tallennettuna:
| Julkaisussa: | Respir Med Case Rep |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7215148/ https://ncbi.nlm.nih.gov/pubmed/32399393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101087 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|